查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1579749

全球胆管支架市场

Biliary Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球胆管支架市场将达到7.978亿美元

2023年全球胆管支架市场预估为6.136亿美元，预估至2030年将达7.978亿美元，2023-2030年分析期间复合年增长率为3.8%。门诊手术中心最终用途是本报告分析的细分市场之一，预计复合年增长率为 3.5%，到分析期结束时将达到 3.69 亿美元。分析期间，医院最终用途细分市场的复合年增长率预计为 4.2%。

美国市场预估价值1.66亿美元，中国预期复合年增长率为6.3%

预计2023年美国胆道支架市场规模将达1.66亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到1.624亿美元，2023-2030年分析期间复合年增长率为6.3%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.1% 和 3.1%。在欧洲，德国的复合年增长率预计为 2.5%。

全球胆道支架市场 - 主要趋势和驱动因素总结

什么是胆管支架？

胆道支架是一种小型管状装置，插入胆管以保持其通畅并确保胆汁从肝臟正常流动到肠道。这些支架主要用于治疗因胆管癌、胰臟癌、胆结石以及疤痕或发炎引起的良性狭窄等疾病引起的胆管阻塞。胆管阻塞可导致严重的併发症，如黄疸、胆汁性肝硬化和危及生命的感染疾病，如胆管炎。胆道支架可透过打开胆汁排放途径来缓解这些阻塞，从而减轻症状并预防併发症。支架大致分为两种：塑胶支架和金属支架。塑胶支架随着时间的推移有闭塞的倾向，因此通常用于短期管理，而自膨胀金属支架（SEMS）具有较大的管腔并且不太可能闭塞，因此它们用于长期管理。根据阻塞的性质，胆道支架可以透过内视镜或经皮放置，被认为是安宁疗护和术前介入的重要工具，可改善患者的治疗效果和生活品质。胆道支架可以减轻症状并改善胆汁流动，已成为治疗恶性和良性胆道疾病的基石。

技术进步是否使胆管支架更有效？

最近的技术进步显着提高了胆管支架的功效、耐用性和安全性，扩大了其应用范围并改善了患者的治疗结果。最显着的进步之一是覆膜自膨式金属支架 (CSEMS) 的出现，其设计目的是防止组织浸润和迁移，这是传统金属支架的常见问题。这些支架涂有聚四氟乙烯 (PTFE) 和硅胶等生物相容性材料，可提供有效的屏障，最大限度地减少肿瘤过度生长并延长支架的通畅性。防支架迁移特征的使用，例如扩口端和锚固机制，进一步降低了支架迁移的风险，这是併发症。此外，随着时间的推移逐渐溶解的生物分解性支架的引入为良性狭窄提供了一种有前途的解决方案，消除了支架移除手术的需要。支架上涂有化疗和抗增生剂，可局部释放药物抑制肿瘤生长和疤痕组织形成，延长支架的功能寿命。支架输送系统的改进也发挥了重要作用，即使在曲折的解剖结构中，新设备也可以实现更精确的放置。这些输送系统现在在影像引导下具有改进的可推动性、灵活性和可见性，使胃肠病学家和介入放射科医生能够更轻鬆地导航复杂的胆管结构。这些技术进步不仅提高了胆道支架的功效和安全性，也扩大了其在恶性和良性胆道疾病治疗中的作用。

不断变化的治疗模式和患者人口统计如何影响胆道支架市场？

不断发展的治疗模式、全球人口老化以及胆道和胰臟疾病发病率的增加正在塑造胆道支架市场。由于老化、肥胖和酒精相关肝病等因素导致肝胆癌的盛行率持续上升，对有效胆道减压解决方案的需求正在迅速增加。这导致了治疗策略的转变，胆道支架在安宁疗护和根治性介入中日益发挥核心作用。例如，对于无法手术的胆管癌或胰臟癌患者，胆道置入术可以有效缓解黄疸等症状，改善患者的生活品质，并有利于化疗，现在已成为治疗方案的标准部分。此外，微创内视镜逆行性造影（ERCP）手术的广泛使用增加了对可以更精确地部署和更少併发症的支架的需求。患者人口统计也影响市场趋势，因为世界人口老化导致胆管阻塞和相关併发症的盛行率增加。这些人口趋势推动了对更耐用、更持久的支架选择的需求，这些支架可以减少可能不适合再次手术的老年患者的再次手术频率，这激励着我。此外，人们越来越重视以患者为中心的设计，优先考虑舒适性和易于放置，并为儿科和青少年患者开发专用支架。这种客製化解决方案的趋势进一步推动创新，并为製造商创造机会，根据临床表现和患者结果来区分其产品。

推动胆道支架市场快速成长的因素有哪些？

胆道支架市场的成长是由多种因素推动的，例如胆道疾病盛行率的增加、支架设计的技术进步以及微创手术的日益采用。胆道阻塞的盛行率不断增加，特别是在肝胆胰癌发生率不断增加的背景下，是主要的促进因素之一，而胆道支架是控制受影响患者症状和改善生活品质的重要姑息干预措施。自膨胀金属支架（SEMS）、覆膜支架和生物分解性支架等创新也透过解决支架闭塞和移位等常见併发症来延长支架寿命，减少翻修手术的需要，这极大地促进了市场成长。此外，ERCP 和经皮置入术等微创手术的趋势表明，与传统手术方法相比，这些手术具有更快的恢復时间和更低的併发症率，因此，我们正在扩大胆道支架的使用。人们对胆道疾病的认识不断提高，及早发现，再加上对内视镜介入的日益偏好，进一步增加了对先进支架置入术的需求。此外，世界人口老化，更容易患上胆管癌、胆结石和其他胆道疾病，这增加了对有效和持久的支架解决方案的需求。最后，医疗保健行业对基于价值的医学的重视正在推动向提供临床疗效和成本效率的支架的转变，改善患者的治疗效果，同时减轻医疗保健系统的总体负担。来改善。这些不同的因素正在改变胆道支架市场，随着对有效胆道引流解决方案的需求持续成长，胆道支架市场可望持续成长。

受访企业范例（共42例）

  • Blue Belt Technologies
  • Boston Scientific Corporation
  • Brainlab
  • Claron Technology
  • Fiagon
  • GE Healthcare
  • Karl Storz
  • MAKO
  • Medacta International
  • Medtronic plc
  • Micromar
  • OrthAlign
  • Scopis
  • Stryker Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP17706

Global Biliary Stents Market to Reach US$797.8 Million by 2030

The global market for Biliary Stents estimated at US$613.6 Million in the year 2023, is expected to reach US$797.8 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Ambulatory Surgery Centers End-Use, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$369.0 Million by the end of the analysis period. Growth in the Hospitals End-Use segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$166.0 Million While China is Forecast to Grow at 6.3% CAGR

The Biliary Stents market in the U.S. is estimated at US$166.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$162.4 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Biliary Stents Market - Key Trends and Drivers Summarized

What Are Biliary Stents and Why Are They Used?

Biliary stents are small, tubular devices inserted into the bile duct to maintain its patency and ensure the proper flow of bile from the liver to the intestine. These stents are primarily used in the treatment of bile duct obstructions caused by conditions such as cholangiocarcinoma (bile duct cancer), pancreatic cancer, gallstones, or benign strictures due to scarring and inflammation. Obstruction in the bile duct can lead to serious complications, including jaundice, biliary cirrhosis, and life-threatening infections such as cholangitis. Biliary stents help alleviate these blockages by providing a pathway for bile drainage, reducing symptoms, and preventing complications. The stents are categorized into two major types: plastic and metal. Plastic stents are generally used for short-term management due to their tendency to occlude over time, while self-expanding metallic stents (SEMS) are preferred for longer-term solutions because they provide a larger lumen and resist clogging. Biliary stents can be placed endoscopically or percutaneously depending on the nature of the obstruction, and are considered an essential tool in both palliative care and preoperative interventions to improve patient outcomes and quality of life. With their ability to reduce symptoms and improve bile flow, biliary stents have become a cornerstone in the management of malignant and benign biliary diseases.

How Are Technological Advances Making Biliary Stents More Effective?

Recent technological advancements have significantly enhanced the efficacy, durability, and safety of biliary stents, broadening their applications and improving patient outcomes. One of the most noteworthy developments is the advent of covered self-expanding metallic stents (CSEMS), which are designed to prevent tissue ingrowth and migration, common issues with traditional metal stents. These stents are coated with biocompatible materials such as polytetrafluoroethylene (PTFE) or silicone, providing an effective barrier that minimizes tumor overgrowth and prolongs stent patency. The use of anti-migration features, such as flared ends and anchoring mechanisms, has further reduced the risk of stent displacement, a complication that can necessitate repeat interventions. Additionally, the introduction of biodegradable stents, which gradually dissolve over time, offers a promising solution for benign strictures, eliminating the need for stent removal procedures. Another major innovation is the use of drug-eluting stents, which are coated with chemotherapeutic agents or anti-proliferative drugs that release medication locally to inhibit tumor growth or scar tissue formation, thereby extending the functional life of the stent. Improvements in stent delivery systems have also played a crucial role, with newer devices allowing for more precise deployment even in tortuous anatomy. These delivery systems are now equipped with enhanced pushability, flexibility, and visibility under imaging guidance, enabling gastroenterologists and interventional radiologists to navigate complex bile duct anatomy with greater ease. Such technological advancements are not only improving the effectiveness and safety profile of biliary stents but are also expanding their role in the management of both malignant and benign biliary conditions.

How Are Shifting Treatment Paradigms and Patient Demographics Shaping the Biliary Stent Market?

The biliary stent market is being shaped by evolving treatment paradigms, an aging global population, and the increasing incidence of biliary and pancreatic diseases. As the prevalence of hepatobiliary cancers continues to rise, driven by factors such as aging populations, obesity, and alcohol-related liver diseases, the demand for effective biliary decompression solutions is growing rapidly. This has led to a shift in treatment strategies, with biliary stents playing an increasingly central role in both palliative care and curative interventions. For instance, in patients with inoperable cholangiocarcinoma or pancreatic cancer, biliary stenting is now a standard part of the management protocol, as it effectively alleviates jaundice and other symptoms, improving the patient’s quality of life and facilitating chemotherapy. Furthermore, the expanding use of minimally invasive endoscopic retrograde cholangiopancreatography (ERCP) procedures has driven demand for stents that can be deployed with greater precision and fewer complications. Patient demographics are also influencing market trends, as an aging global population leads to a higher prevalence of bile duct obstructions and related complications. This demographic trend has spurred the need for more durable, long-lasting stent options that can reduce the frequency of reinterventions in elderly patients who may not be ideal candidates for repeated procedures. Moreover, there is a growing emphasis on patient-centric designs that prioritize comfort and ease of placement, as well as the development of specialized stents for pediatric and adolescent patients. This trend toward tailored solutions is further driving innovation and creating opportunities for manufacturers to differentiate their products based on clinical performance and patient outcomes.

What Factors Are Driving the Rapid Growth of the Biliary Stent Market?

The growth in the biliary stent market is driven by several factors, including the increasing prevalence of biliary diseases, technological advancements in stent design, and the rising adoption of minimally invasive procedures. The growing incidence of biliary obstructions, particularly in the context of rising hepatobiliary and pancreatic cancers, is one of the primary drivers, as biliary stents are a key palliative intervention for managing symptoms and improving the quality of life in affected patients. Technological innovations, such as the development of self-expanding metal stents (SEMS), covered stents, and biodegradable stents, are also contributing significantly to market growth by addressing common complications like stent occlusion and migration, thereby extending stent longevity and reducing the need for repeat procedures. Additionally, the trend toward minimally invasive techniques, such as ERCP and percutaneous stenting, is expanding the use of biliary stents as these procedures are associated with shorter recovery times and lower complication rates compared to traditional surgical approaches. Increased awareness and early detection of biliary diseases, coupled with a growing preference for endoscopic interventions, are further bolstering the demand for advanced stenting options. Moreover, the aging global population, which is more susceptible to conditions like cholangiocarcinoma, gallstone disease, and other biliary pathologies, is driving the need for effective and durable stenting solutions. Finally, the healthcare industry’s emphasis on value-based care is prompting a shift toward stents that offer both clinical efficacy and cost-efficiency, leading to increased adoption of innovative stent technologies that improve patient outcomes while reducing the overall burden on healthcare systems. These diverse factors are transforming the biliary stent market, positioning it for sustained growth as the demand for effective biliary drainage solutions continues to rise.

Select Competitors (Total 42 Featured) -

  • Blue Belt Technologies
  • Boston Scientific Corporation
  • Brainlab
  • Claron Technology
  • Fiagon
  • GE Healthcare
  • Karl Storz
  • MAKO
  • Medacta International
  • Medtronic plc
  • Micromar
  • OrthAlign
  • Scopis
  • Stryker Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Biliary Stents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Biliary Diseases Throws the Spotlight on Stenting Solutions
    • Increasing Adoption of Minimally Invasive Procedures Drives Demand for Biliary Stents
    • Technological Innovations in Stent Design Propel Growth with Enhanced Patency Rates
    • Here's the Story: Expanding Geriatric Population Base Sustains Growth in Biliary Stent Adoption
    • Emergence of Metal & Bioabsorbable Stents Expands Addressable Market for Advanced Solutions
    • Here's How Rising Incidence of Pancreatic & Liver Cancers Spurs Demand in Oncology Applications
    • Rising Awareness of Non-Surgical Treatment Options Drives Adoption in High-Risk Patient Groups
    • Shift Toward Personalized Medicine Generates Opportunities for Customized Stent Solutions
    • Growing Preference for Endoscopic Ultrasound-Guided Procedures Expands Stent Utilization
    • Innovations in Coating Materials & Drug-Eluting Technologies Create Niche Growth Potential
    • Improved Imaging Techniques for Diagnosis & Placement Accelerate Adoption in Complex Cases
    • Rising Focus on Reducing Post-Procedural Complications Spurs Innovations in Stent Engineering
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Biliary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Biliary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • JAPAN
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • CHINA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • EUROPE
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Biliary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • FRANCE
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • GERMANY
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Biliary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • INDIA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Biliary Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Biliary Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
  • AFRICA
    • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030

IV. COMPETITION